These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

986 related items for PubMed ID: 15287092

  • 61. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation.
    Kim M, Park SY, Pai HS, Kim TH, Billiar TR, Seol DW.
    Cancer Res; 2004 Jun 15; 64(12):4078-81. PubMed ID: 15205314
    [Abstract] [Full Text] [Related]

  • 62. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):543-52. PubMed ID: 18793956
    [Abstract] [Full Text] [Related]

  • 63. Overexpression of BAD potentiates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand treatment in the prostatic carcinoma cell line LNCaP.
    Taghiyev AF, Guseva NV, Harada H, Knudson CM, Rokhlin OW, Cohen MB.
    Mol Cancer Res; 2003 May 01; 1(7):500-7. PubMed ID: 12754297
    [Abstract] [Full Text] [Related]

  • 64. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.
    Jin H, Yang R, Fong S, Totpal K, Lawrence D, Zheng Z, Ross J, Koeppen H, Schwall R, Ashkenazi A.
    Cancer Res; 2004 Jul 15; 64(14):4900-5. PubMed ID: 15256461
    [Abstract] [Full Text] [Related]

  • 65. Low-dose UV-radiation sensitizes keratinocytes to TRAIL-induced apoptosis.
    Qin JZ, Bacon P, Panella J, Sitailo LA, Denning MF, Nickoloff BJ.
    J Cell Physiol; 2004 Jul 15; 200(1):155-66. PubMed ID: 15137068
    [Abstract] [Full Text] [Related]

  • 66. Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3.
    Abdollahi T, Robertson NM, Abdollahi A, Litwack G.
    Cancer Res; 2003 Aug 01; 63(15):4521-6. PubMed ID: 12907626
    [Abstract] [Full Text] [Related]

  • 67. TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway.
    Wendt J, von Haefen C, Hemmati P, Belka C, Dörken B, Daniel PT.
    Oncogene; 2005 Jun 09; 24(25):4052-64. PubMed ID: 15806163
    [Abstract] [Full Text] [Related]

  • 68. Reduced response of prostate cancer cells to TRAIL is modulated by NFkappaB-mediated inhibition of caspases and Bid activation.
    Eid MA, Lewis RW, Abdel-Mageed AB, Kumar MV.
    Int J Oncol; 2002 Jul 09; 21(1):111-7. PubMed ID: 12063557
    [Abstract] [Full Text] [Related]

  • 69. [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells].
    Tong HX, Zhang JH, Ma L, Lu CW, Zhang JH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug 09; 8(4):327-30. PubMed ID: 16923369
    [Abstract] [Full Text] [Related]

  • 70. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR.
    Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135
    [Abstract] [Full Text] [Related]

  • 71. A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents.
    Arizono Y, Yoshikawa H, Naganuma H, Hamada Y, Nakajima Y, Tasaka K.
    Br J Cancer; 2003 Jan 27; 88(2):298-306. PubMed ID: 12610517
    [Abstract] [Full Text] [Related]

  • 72. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L, Gu J, Lin T, Huang X, Roth JA, Fang B.
    Gene Ther; 2002 Sep 27; 9(18):1262-70. PubMed ID: 12215894
    [Abstract] [Full Text] [Related]

  • 73. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
    Aggarwal BB, Bhardwaj U, Takada Y.
    Vitam Horm; 2004 Sep 27; 67():453-83. PubMed ID: 15110190
    [Abstract] [Full Text] [Related]

  • 74. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP.
    Cancer Res; 2005 Mar 15; 65(6):2344-52. PubMed ID: 15781649
    [Abstract] [Full Text] [Related]

  • 75. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
    Pei Z, Chu L, Zou W, Zhang Z, Qiu S, Qi R, Gu J, Qian C, Liu X.
    Hepatology; 2004 May 15; 39(5):1371-81. PubMed ID: 15122766
    [Abstract] [Full Text] [Related]

  • 76. IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression.
    Wang SH, Mezosi E, Wolf JM, Cao Z, Utsugi S, Gauger PG, Doherty GM, Baker JR.
    Oncogene; 2004 Jan 29; 23(4):928-35. PubMed ID: 14647456
    [Abstract] [Full Text] [Related]

  • 77. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL.
    Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H, Bamberg M, Schulze-Osthoff K, Budach W.
    Oncogene; 2001 Apr 19; 20(17):2190-6. PubMed ID: 11360204
    [Abstract] [Full Text] [Related]

  • 78. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
    Higuchi H, Bronk SF, Taniai M, Canbay A, Gores GJ.
    J Pharmacol Exp Ther; 2002 Nov 19; 303(2):461-7. PubMed ID: 12388624
    [Abstract] [Full Text] [Related]

  • 79. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.
    Mori T, Doi R, Toyoda E, Koizumi M, Ito D, Kami K, Kida A, Masui T, Kawaguchi Y, Fujimoto K.
    Surgery; 2005 Jul 19; 138(1):71-7. PubMed ID: 16003319
    [Abstract] [Full Text] [Related]

  • 80. Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.
    Panichakul T, Intachote P, Wongkajorsilp A, Sripa B, Sirisinha S.
    Anticancer Res; 2006 Jul 19; 26(1A):259-65. PubMed ID: 16475706
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.